Eloxx Pharmaceuticals News - ELOX

Company Name	Stock Ticker Symbol	Market	Type
Eloxx Pharmaceuticals Inc	ELOX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	3.82	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			3.82	3.82

more quote information »

Recent News

Date	Time	Source	Heading
4/16/2024	07:30	GLOBE	Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program..
4/01/2024	16:02	EDGAR2	Form NT 10-K - Notification of inability to timely file Form..
3/29/2024	16:11	EDGAR2	Form 8-K - Current report
3/21/2024	14:20	EDGAR2	Form 25-NSE - Notification filed by national security..
3/14/2024	16:30	EDGAR2	Form 8-K - Current report
3/13/2024	11:42	GLOBE	Almirall and Eloxx Pharmaceuticals Enter into Exclusive..
1/26/2024	16:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/26/2024	16:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/26/2024	16:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/26/2024	16:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/24/2024	21:44	EDGAR2	Form S-3 - Registration statement under Securities Act of..
1/24/2024	17:11	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
1/09/2024	17:10	EDGAR2	Form 8-K - Current report
12/28/2023	16:11	EDGAR2	Form 8-K - Current report
11/13/2023	16:15	GLOBE	Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial..
10/16/2023	17:26	EDGAR2	Form 8-K - Current report
10/09/2023	08:00	GLOBE	Eloxx Pharmaceuticals Reports Additional Confirmation that..
9/20/2023	16:05	EDGAR2	Form 8-K - Current report
9/20/2023	13:26	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
9/19/2023	08:00	GLOBE	Eloxx Pharmaceuticals Announces $2 Million Registered Direct..
9/18/2023	08:05	EDGAR2	Form 8-K - Current report
9/18/2023	07:00	GLOBE	Eloxx Pharmaceuticals Reports Independent Confirmation of..
9/15/2023	17:15	EDGAR2	Form 8-K - Current report
9/07/2023	10:14	EDGAR2	Form 8-K - Current report
9/07/2023	09:00	GLOBE	Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and..
8/29/2023	16:32	EDGAR2	Form 8-K - Current report
8/21/2023	16:50	EDGAR2	Form 8-K - Current report
8/14/2023	11:56	EDGAR2	Form 8-K - Current report
8/14/2023	08:30	GLOBE	Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial..
8/14/2023	08:00	GLOBE	Eloxx Pharmaceuticals Reports Drug Response in All Patients..
8/11/2023	16:11	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/11/2023	16:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	16:01	EDGAR2	Form 8-K - Current report
8/03/2023	09:26	GLOBE	Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain..
7/13/2023	08:43	EDGAR2	Form 8-K - Current report
7/10/2023	09:00	GLOBE	Eloxx Pharmaceuticals Announces Publication Demonstrating..
6/28/2023	09:00	GLOBE	Eloxx Pharmaceuticals Key Opinion Leader Event Highlights..
6/21/2023	13:30	GLOBE	Eloxx Pharmaceuticals to Host Investor and Analyst Call on..
6/21/2023	09:00	GLOBE	Eloxx Pharmaceuticals Highlights Recent Alport Syndrome..
6/14/2023	16:53	GLOBE	Eloxx Pharmaceuticals Announces Final Data Assessment from..
6/06/2023	08:30	GLOBE	Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain..
6/01/2023	09:10	GLOBE	Atossa Appoints Life Sciences Financial and Operations..
5/24/2023	08:00	GLOBE	Eloxx Pharmaceuticals Intends to Advance ELX-02 into Pivotal..
5/15/2023	16:30	GLOBE	Eloxx Pharmaceuticals Reports First Quarter 2023 Financial..
5/02/2023	08:00	GLOBE	Eloxx Pharmaceuticals Announces FDA Clearance to Begin..